Articles from Amulet Capital Partners, LP

Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced that Adam Grossman has joined the firm as a Partner. In this role, Mr. Grossman will focus on sourcing, structuring, and working closely with management teams to build and scale healthcare services platforms.

Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced the sale of SSI Strategy (“SSI”), a trusted strategic consulting partner to biotech innovators, to Clinigen, the global pathfinder accelerating patient access to critical medicines across the lifecycle. Financial terms of the transaction were not disclosed.

Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced a new platform investment in Theoria Management, LLC (“Theoria” or the “Company”), an innovative, tech-enabled management service organization providing for the delivery of high-quality, value-based primary care services to senior living communities across the United States. Justin Di Rezze, MD, founder of Theoria, will continue to lead the business as Chief Executive Officer and will remain a significant shareholder in the Company. Financial terms of the transaction were not disclosed.

Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced that Michael Keaveney has joined the firm as a Partner and Head of Investor Relations. Mr. Keaveney will oversee the firm’s capital formation, fundraising and investor engagement initiatives, and will work closely with the firm’s leadership team and investment committee to grow the firm’s diversified investor base around the world.

Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced it has acquired the Genetics & IVF Institute (“GIVF” or the “Company), a leading provider of reproductive tissue banking and related reproductive technology services. The transaction includes significant co-investment from a consortium of Amulet Limited Partners. Financial terms of the transaction were not disclosed.

Amulet Capital Partners, LP ("Amulet”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced the closing of Amulet Capital Fund III ("Fund III”) with approximately $1.2 billion in capital commitments. The oversubscribed fund represents commitments from a diverse range of global institutional investors, including state and corporate pension funds, endowments, foundations and family offices. Following the close, Amulet now manages approximately $2.7 billion in assets.

Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced it has acquired Alliance Clinical Network (“ACN”), a leading comprehensive clinical site platform. Financial terms of the transaction were not disclosed.

Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced a significant growth investment in minds + assembly (“m+a” or the “Company”), an industry-leading full-service, design-centric agency and commercialization platform focused on the healthcare sector. Terms of the transaction were not disclosed.

Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced that it has acquired United Vein & Vascular Centers (“UVVC” or the “Company”), a leading provider of high-quality vascular care treatment services. Financial terms of the transaction were not disclosed.

Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector, announced today that it has recapitalized Lighthouse Behavioral Health Solutions (“Lighthouse”), a leading network of outpatient substance abuse and mental health treatment facilities headquartered in Columbus, Ohio.

Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm focused exclusively on the healthcare sector, today announced the promotion of Gabriel Luft to Partner, effective January 1, 2022.

Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector, announced today that is has acquired Remedy Health Media (“Remedy”), a leading digital health platform that serves patients, caregivers and healthcare providers through a family of trusted health information websites.

Amulet Capital Partners, LP (“Amulet”), a middle-market private equity investment firm based in Greenwich, CT, focused exclusively on the healthcare sector, announced today the closing of its second fund, Amulet Capital Partners II (the “Fund”). The Fund, executed as a mostly virtual process, was oversubscribed and closed with in excess of $650 million in capital commitments, exceeding the Fund’s target of $500 million. The firm’s thematic approach to healthcare investing, focusing on complex and advantaged situations as well as a consistent approach to driving value post-acquisition, attracted strong support from new and existing investors.

SSI Strategy, LLC (“SSI” or the “Company”), a leading Life Sciences consultancy, announced today that they have acquired Fiore Healthcare Advisors, LLC (FHA), a leading Pharmacovigilance consultancy and long-time SSI collaborative partner. This news comes on the heels of SSI’s December 2020 growth investment from Amulet Capital Partners, LP (“Amulet”), a middle-market private equity firm focused exclusively on the Healthcare sector.